Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1985 2
1986 1
1987 2
1992 2
1993 1
1994 1
1995 1
1996 1
1997 1
2000 1
2001 1
2003 1
2004 1
2005 2
2006 3
2007 2
2009 2
2011 2
2012 2
2013 1
2014 1
2015 3
2016 2
2017 4
2018 1
2019 2
2020 1
2021 1
2023 2
2024 1
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis.
Baeten D, Sieper J, Braun J, Baraliakos X, Dougados M, Emery P, Deodhar A, Porter B, Martin R, Andersson M, Mpofu S, Richards HB; MEASURE 1 Study Group; MEASURE 2 Study Group. Baeten D, et al. N Engl J Med. 2015 Dec 24;373(26):2534-48. doi: 10.1056/NEJMoa1505066. N Engl J Med. 2015. PMID: 26699169 Free article. Clinical Trial.
Comparison of Standard-of-Care Idecabtagene Vicleucel and Ciltacabtagene Autoleucel in Relapsed/Refractory Multiple Myeloma.
Hansen DK, Peres LC, Dima D, Richards A, Shune L, Afrough A, Midha S, Dhakal B, Kocoglu MH, Atrash S, Ferreri C, Castaneda O, Davis JA, Bhurtel E, McGuirk J, Wagner C, Bansal R, Costello P, Smith K, Lieberman-Cribbin A, De Avila G, Purvey S, Hosoya H, Mikkilineni L, Oswald LB, Kaur G, Pasvolsky O, Gaballa M, Herr MM, Forsberg P, Janakiram M, Htut M, Asoori Maringanti S, Kalariya N, Hashmi H, Reshef R, Sborov DW, Nadeem O, Anwer F, Khouri J, Raza S, Atanackovic D, Alsina M, Freeman CL, Locke FL, Voorhees P, Anderson LD Jr, Richard S, Martin T, Lin Y, Patel KK, Sidana S; US Multiple Myeloma Immunotherapy Consortium. Hansen DK, et al. Among authors: castaneda o. J Clin Oncol. 2025 May;43(13):1597-1609. doi: 10.1200/JCO-24-01730. Epub 2025 Feb 18. J Clin Oncol. 2025. PMID: 39965175
Erratum: Comparison of Standard-of-Care Idecabtagene Vicleucel and Ciltacabtagene Autoleucel in Relapsed/Refractory Multiple Myeloma.
Hansen DK, Peres LC, Dima D, Richards A, Shune L, Afrough A, Midha S, Dhakal B, Kocoglu MH, Atrash S, Ferreri C, Castaneda O, Davis JA, Bhurtel E, McGuirk J, Wagner C, Bansal R, Costello P, Smith K, Lieberman-Cribbin A, De Avila G, Purvey S, Hosoya H, Mikkilineni L, Oswald LB, Kaur G, Pasvolsky O, Gaballa M, Herr MM, Forsberg P, Janakiram M, Htut M, Maringanti SA, Kalariya N, Hashmi H, Reshef R, Sborov DW, Nadeem O, Anwer F, Khouri J, Raza S, Atanackovic D, Alsina M, Freeman CL, Locke FL, Voorhees P, Anderson LD Jr, Richard S, Martin T, Lin Y, Patel KK, Sidana S; US Multiple Myeloma Immunotherapy Consortium. Hansen DK, et al. Among authors: castaneda o. J Clin Oncol. 2025 Apr 10;43(11):1399. doi: 10.1200/JCO-25-00453. Epub 2025 Mar 7. J Clin Oncol. 2025. PMID: 40053892 No abstract available.
Teclistamab for patients with heavily pretreated relapsed/refractory multiple myeloma and renal impairment.
Dima D, Afrough A, Goel U, Grajales-Cruz AF, Khouri J, Julian K, Pasvolsky O, Banerjee R, Razzo B, Ferreri CJ, Vazquez-Martinez MA, Davis JA, Sannareddy A, Castaneda O, Raza S, Portuguese AJ, Gaballa MR, Rana MS, Lieberman-Cribbin A, DeJarnette S, Gonzalez R, Chen A, Herr MM, Mikkilineni L, Hosoya H, Ouchveridze E, Kaur G, Rossi A, Shune L, Anwer F, Lin Y, Richard S, Sborov DW, Baz RC, Garfall AL, Lee HC, Anderson LD Jr, Cowan AJ, Patel KK, Voorhees PM, Sidana S, Hansen DK, Atrash S, Susanibar-Adaniya SP. Dima D, et al. Among authors: castaneda o. Blood Adv. 2025 Jul 22;9(14):3408-3417. doi: 10.1182/bloodadvances.2025016059. Blood Adv. 2025. PMID: 40198766 Free PMC article.
Multiple Myeloma Genomics - A Concise Review.
Castaneda O, Baz R. Castaneda O, et al. Acta Med Acad. 2019 Apr;48(1):57-67. doi: 10.5644/ama2006-124.242. Acta Med Acad. 2019. PMID: 31264433 Free article. Review.
Potassium channel toxins and transmitter release.
Harvey AL, Rowan EG, Vatanpour H, Fatehi M, Castaneda O, Karlsson E. Harvey AL, et al. Among authors: castaneda o. Ann N Y Acad Sci. 1994 Mar 9;710:1-10. doi: 10.1111/j.1749-6632.1994.tb26609.x. Ann N Y Acad Sci. 1994. PMID: 8154739 Review. No abstract available.
50 results